On May 13, 2020, the New York Department of Financial Services ("NYDFS") sent separate Section 308 information requests related to impact of the COVID-19 pandemic to all property/casualty and life insurance companies authorized in New York. Section 308 of the New York Insurance Law authorizes the NYDFS to require New York-licensed insurers to submit written special reports on any topics specified in the NYDFS information request.

Property/Casualty("P&C") Insurance Letter

The first letter requires all insurers that write "Commercial Liability Policies" (defined as including but not limited to Commercial General Liability, Directors & Officers, Commercial Umbrella, Commercial Excess, Professional Liability, Business Owner, Commercial Multiple Peril, and Specialized Multiple Peril) to provide the following information:

  • An explanation of any communicable disease exclusions or similar exclusions that the insurer might use to deny coverage for claims relating to COVID-19;
  • An explanation of any plan to add COVID-19 exclusions to existing or new policies;
  • An explanation of any decision to stop offering products in New York to avoid COVID-19-related risks; and
  • A list of current policies for which pricing included recognition of potential coverage exposure for COVID-19-like losses.

P&C Insurers have until May 21, 2020, to respond.

Life Insurance &Annuities Letter

The letter to all life insurers authorized in New York has two sections. The first section applies generally, and the second section applies specifically to insurers that offer an accelerated or algorithmic underwriting program.

The general section includes broad survey questions, requiring insurers to:

Provide:

  • Statistical information about products the insurer offers, including how many of each type it has issued in the first four months of 2020, whether these numbers represent an increase or decrease, and whether the products are targeted at specific age groups or demographics;
  • Any new product filings the insurer plans to make; and
  • The notice the insurer is providing to its sales force before implementation of new products or changes to existing products.

And describe:

  • The insurer's current practices and experience, including changes due to mortality risk, morbidity risk, interest rates, default risk, and risk of financial loss due to recent changes in equity and other financial markets;
  • The changes the insurer has made in life insurance and annuity product pricing for new sales;
  • The changes the insurer has made in life insurance and annuity product pricing for existing customers;
  • The role of the company's reinsurers in any pricing changes; and
  • The changes the insurer has made in underwriting life insurance and annuities.

The second section requires insurers offering accelerated or algorithmic underwriting programs to provide the following information:

  • Whether the insurer uses external consumer data or information sources to supplement medical (i.e., paramedical exam or physically invasive) underwriting (other than an attending physician's statement; MIB Group, Inc. member information exchange; motor vehicle report; inspection report or prescription drug database);
  • A list of the policies for which the insurer uses external data in underwriting;
  • Any limitations on the use of external data;
  • A description of the external data used and its use;
  • A description of how the insurer obtains the external data;
  • A description of how the insurer informs the applicant about what information is being obtained;
  • The process or recourse provided to applicants who receive an adverse underwriting decision based on external data; and
  • A description of how external data is used, stored and disposed of after the underwriting process.

Most, if not all, of the information requests relating to accelerated/algorithmic underwriting are similar to the ones included in the NYDFS survey that preceded the issuance of "Circular Letter No. 1 re: Use of External Consumer Data and Information Sources in Underwriting for Life Insurance" in January 2019.

Insurers have until May 19, 2020, to respond to the questions in the first generally applicable section and until May 29, 2020, to respond to the algorithmic/accelerated underwriting questions.

Originally published May 14 2020

Visit us at mayerbrown.com

Mayer Brown is a global legal services provider comprising legal practices that are separate entities (the "Mayer Brown Practices"). The Mayer Brown Practices are: Mayer Brown LLP and Mayer Brown Europe - Brussels LLP, both limited liability partnerships established in Illinois USA; Mayer Brown International LLP, a limited liability partnership incorporated in England and Wales (authorized and regulated by the Solicitors Regulation Authority and registered in England and Wales number OC 303359); Mayer Brown, a SELAS established in France; Mayer Brown JSM, a Hong Kong partnership and its associated entities in Asia; and Tauil & Chequer Advogados, a Brazilian law partnership with which Mayer Brown is associated. "Mayer Brown" and the Mayer Brown logo are the trademarks of the Mayer Brown Practices in their respective jurisdictions.

© Copyright 2020. The Mayer Brown Practices. All rights reserved.

This Mayer Brown article provides information and comments on legal issues and developments of interest. The foregoing is not a comprehensive treatment of the subject matter covered and is not intended to provide legal advice. Readers should seek specific legal advice before taking any action with respect to the matters discussed herein.